Clinical Trials Logo

Filter by:
NCT ID: NCT01674452 Completed - Stroke Clinical Trials

Home-based Exercises for Patients With Stroke

Start date: January 2010
Phase: N/A
Study type: Interventional

The aim of this study is the development and the implementation of a new protocol about home-based exercises, supported by an illustrated manual, for the treatment of individuals with stroke. The hypothesis is that this group of patients who are going to carry out the training of this study protocol are going to show improvement in measured parameters (functionality and physical performance), which allows this protocol to be improved and published as a proposal of physiotherapeutic treatment.

NCT ID: NCT01674439 Completed - Clinical trials for Craniofacial Microsomia

Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells

Start date: January 2010
Phase: Phase 2
Study type: Interventional

Although first reports of the clinical use of adipose-derived regenerative cells (ADRC) suggest that this approach may be feasible and effective for soft tissue augmentation, there is a lack of randomized, controlled clinical trials in the literature. Hence, this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia.

NCT ID: NCT01673867 Completed - Clinical trials for Non-Squamous Cell Non-small Cell Lung Cancer

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

CheckMate057
Start date: November 2, 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy

NCT ID: NCT01672619 Completed - Clinical trials for Children With Craniosynostoses

Nautilus: Dynamic Craniotomy; New Surgical Technique and Preliminary Results

Nautilus
Start date: June 2010
Phase: N/A
Study type: Observational

Being the craniostenoses sutural basically a disease, the fact that the brain being trapped in an enclosure that does not have complacency required to accompany their growth constitutes the challenge of treatment, which aims to restore the complacency of the suture and correct the stenotic compensatory cranial deformity. This paper proposes the combination of a helicoid osteotomy distraction osteogenesis provided by the use of springs distracting.

NCT ID: NCT01671046 Completed - Clinical trials for Hepatitis C, Chronic

An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection

Start date: July 2012
Phase: N/A
Study type: Observational

This multi-center, prospective observational study will evaluate the correlation of liver biopsy and transient elastography in liver fibrosis assessment in patients with chronic hepatitis C. Data will be collected for 96 weeks.

NCT ID: NCT01670786 Completed - Clinical trials for Pleural Effusion, Malignant

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Start date: January 2010
Phase: Phase 4
Study type: Interventional

Iodopovidone is safe when using as a pleurodesis sclerosing agent for malignant pleural effusion, with minimal adverse events, especially reducing dose.

NCT ID: NCT01670552 Completed - Dyspepsia Clinical Trials

Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

Start date: February 17, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of an association with one anti-inflammatory and one gastroprotective agent compared to the one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation.

NCT ID: NCT01670305 Completed - Periodontal Disease Clinical Trials

Photodynamic Therapy and Periodontal Therapy. A Clinical, Microbiological and Immunoenzymatic Analysis

Start date: February 2011
Phase: N/A
Study type: Interventional

Residual pockets and furcation defects are challenging sites that require additional periodontal therapy. The aim of this study is evaluate 1)the effect of a single photodynamic therapy (PDT) as monotherapy residual pockets in single rooted teeth and 2) the effect of PDT in association with scaling and root planing (SRP) in class II furcation lesions with probing pocket depth (PPD) >5mm and bleeding on probing (BoP). A blind randomized controlled clinical trial was conducted in subjects presenting at least three residual pockets in single root teeth and subjects with at least one molar presenting class II furcation defect. To evaluate the effect of a single PDT as monotherapy in residual pockets, the selected sites were assigned to receive: PDT alone, photosensitizer alone or SRP alone. To evaluate the effect of PDT in association with SRP in class II furcation lesions, the selected sites were assigned to PDT+SRP or SRP alone. Clinical, microbiological and immunoenzymatic analyses were assessed at baseline, 3 and 6 months post-therapies.

NCT ID: NCT01669577 Completed - Multiple Trauma Clinical Trials

Independent Predictors of Mortality in Polytrauma Patients

Start date: October 2010
Phase: Phase 3
Study type: Observational

Prospective observational trial searching for independent predictors of mortality. Data was collected at trauma scene, ER, three and 24 hours of hospital stay.The patients will be followed for 30 days after hospital admission.

NCT ID: NCT01668966 Completed - Clinical trials for Rheumatoid Arthritis

A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)

Start date: December 9, 2013
Phase: Phase 3
Study type: Interventional

This open-label, single arm, multicenter long-term extension study of WA19926 (NCT01007435) will evaluate the safety and efficacy of tocilizumab in participants with early, moderate to severe RA who have completed the 104-week WA19926 (NCT01007435) core study. Eligible participants will be those who are expected to benefit from the study medicine based on the investigator's discretion.